Melotex Capsule 7.5mg (Meloxicam)

Adult dose

1. Acute exacerbation of osteoarthritis (degenerative arthritis): ○ Adults: Administer meloxicam 7.5 mg orally once daily. If symptoms do not improve, the dose may be increased to 15 mg per day as needed. 2. Rheumatoid arthritis, ankylosing spondylitis: ○ Adults: Administer 15 mg of this medicine orally once daily. The dose may be reduced to 7.5 mg per day according to response to treatment. Do not administer more than 15 mg of this medicine per day. Take with water or another beverage during a meal. ○ In elderly patients or those at increased risk of adverse reactions, treatment is usually started at a dose of 7.5 mg per day. ○ Patients with severe renal impairment receiving hemodialysis should not receive more than 7.5 mg per day.

This drug may pose a risk of gastrointestinal bleeding in those who regularly consume more than three glasses of alcohol daily; therefore, consultation with a doctor or pharmacist is essential. This medication can cause problems with the heart and blood vessels and may increase the risk of serious cardiovascular diseases such as myocardial infarction or stroke. Patients with cardiovascular diseases or risk factors should closely monitor their symptoms and immediately discontinue use if they experience chest pain, shortness of breath, or slurred speech symptoms. This drug can cause serious issues such as gastrointestinal bleeding, ulcers, or perforation, so elderly patients or those with a history of gastrointestinal disorders should exercise particular caution and should consult a doctor immediately if gastrointestinal symptoms occur during use. Rarely, serious allergic reactions or dermatitis, and mucosal damage may occur on the skin; therefore, if any abnormalities occur, the use of this drug should be stopped and a doctor consulted. This drug may affect kidney function, so patients with kidney disease, the elderly, or those taking diuretics should regularly monitor kidney function while using this medication. Pregnant women or those planning to become pregnant should avoid using this medication, and breastfeeding women should also not take this drug. This drug may interact with other non-steroidal anti-inflammatory drugs or anticoagulants, lithium, methotrexate, etc.; therefore, it is essential to consult a doctor or pharmacist if taking other medications. While taking this drug, symptoms such as drowsiness, dizziness, and blurred vision may occur, so caution is needed when driving or operating machinery. This drug should be used at the smallest effective dose and for the shortest possible duration, and regular blood tests and kidney and liver function tests are needed for long-term use. In case of an overdose, symptoms such as vomiting, drowsiness, and gastrointestinal bleeding may appear; seek medical attention immediately for appropriate treatment. This drug should be stored out of the reach of children and sealed in its original container for safety.

• Gastrointestinal bleeding
• cardiovascular thrombotic events
• myocardial infarction
• stroke
• gastric or intestinal bleeding
• ulcers
• perforation
• exfoliative dermatitis
• Stevens-Johnson syndrome
• toxic epidermal necrolysis

This drug should be stored in a sealed container that blocks light, at room temperature between 1 and 30 degrees Celsius. Proper storage helps maintain the drug's effectiveness and prevents degradation.

Appearance

Capsules with yellowish powder in dark green upper and lower parts.

Package unit

30 capsules/bottle, 300 capsules/bottle